![](data:image/png;base64,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)
221
ASAA
Peres MFP, Scala WAR, Salazar R
Comparison between metamizole and triptans for migraine treatment: a systematic review and network meta-analysis
40. Krymchantowski AV, Carneiro H, Barbosa J and Jevoux
C. Lysine clonixinate versus dipyrone (metamizole)
for the acute treatment of severe migraine attacks: a
single-blind, randomized study.
Arq Neuropsiquiatr
2008;66(2a):216-220 Doi:10.1590/s0004-
282x2008000200015
41. Martínez-Martín P, Raffaelli E, Jr., Titus F, Despuig
J, Fragoso YD, Díez-Tejedor E, . . . Ortiz P. Efficacy
and safety of metamizol vs. acetylsalicylic acid
in patients with moderate episodic tension-type
headache: a randomized, double-blind, placebo-
and active-controlled, multicentre study.
Cephalalgia
2001;21(5):604-610 Doi:10.1046/j.1468-
2982.2001.00216.x
42. Tulunay FC, Ergün H, Gülmez SE, Ozbenli T,
Ozmenoğlu M, Boz C, . . . Inan L. The efficacy and
safety of dipyrone (Novalgin) tablets in the treatment
of acute migraine attacks: a double-blind, cross-over,
randomized, placebo-controlled, multi-center study.
Funct Neurol
2004;19(3):197-202
43. Ahonen K, Hämäläinen ML, Eerola M and Hoppu K.
A randomized trial of rizatriptan in migraine attacks
in children.
Neurology
2006;67(7):1135-1140
Doi:10.1212/01.wnl.0000238179.79888.44
44. Ahonen K, Hämäläinen ML, Rantala H and Hoppu
K. Nasal sumatriptan is effective in treatment of
migraine attacks in children: A randomized trial.
Neurology
2004;62(6):883-887 Doi:10.1212/01.
wnl.0000115105.05966.a7
45. Winner P, Rothner AD, Wooten JD, Webster C and
Ames M. Sumatriptan nasal spray in adolescent
migraineurs: a randomized, double-blind, placebo-
controlled, acute study.
Headache
2006;46(2):212-
222 Doi:10.1111/j.1526-4610.2006.00339.x
46. Winner P, Linder SL, Lipton RB, Almas M, Parsons B
and Pitman V. Eletriptan for the acute treatment of
migraine in adolescents: results of a double-blind,
placebo-controlled trial.
Headache
2007;47(4):511-
518 Doi:10.1111/j.1526-4610.2007.00755.x
47. Winner P, Adelman J, Aurora S, Lener ME and Ames
M. Efficacy and tolerability of sumatriptan injection for
the treatment of morning migraine: two multicenter,
prospective, randomized, double-blind, controlled
studies in adults.
Clin Ther
2006;28(10):1582-1591
Doi:10.1016/j.clinthera.2006.10.011
48. Evers S, Rahmann A, Kraemer C, Kurlemann G, Debus
O, Husstedt IW and Frese A. Treatment of childhood
migraine attacks with oral zolmitriptan and ibuprofen.
Neurology
2006;67(3):497-499 Doi:10.1212/01.
wnl.0000231138.18629.d5
49. Fujita M, Sato K, Nishioka H and Sakai F. Oral
sumatriptan for migraine in children and adolescents:
a randomized, multicenter, placebo-controlled,
parallel group study.
Cephalalgia
2014;34(5):365-
375 Doi:10.1177/0333102413510213
50. Hämäläinen ML, Hoppu K and Santavuori P.
Sumatriptan for migraine attacks in children: a
randomized placebo-controlled study. Do children
with migraine respond to oral sumatriptan differently
from adults?
Neurology
1997;48(4):1100-1103
Doi:10.1212/wnl.48.4.1100
51. Ho TW, Pearlman E, Lewis D, Hämäläinen M,
Connor K, Michelson D, . . . Hewitt DJ. Efficacy and
tolerability of rizatriptan in pediatric migraineurs:
results from a randomized, double-blind, placebo-
controlled trial using a novel adaptive enrichment
design.
Cephalalgia
2012;32(10):750-765
Doi:10.1177/0333102412451358
52. Linder SL, Mathew NT, Cady RK, Finlayson G,
Ishkanian G and Lewis DW. Efficacy and tolerability
of almotriptan in adolescents: a randomized,
double-blind, placebo-controlled trial.
Headache
2008;48(9):1326-1336 Doi:10.1111/j.1526-
4610.2008.01138.x
53. Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y,
McCarroll K, . . . Nett R. Rizatriptan 5 mg for the acute
treatment of migraine in adolescents: results from a
double-blind, single-attack study and two open-label,
multiple-attack studies.
Headache
2004;44(9):891-
899 Doi:10.1111/j.1526-4610.2004.04171.x
54. Winner P, Rothner AD, Saper J, Nett R, Asgharnejad
M, Laurenza A, . . . Peykamian M. A randomized,
double-blind, placebo-controlled study of sumatriptan
nasal spray in the treatment of acute migraine
in adolescents.
Pediatrics
2000;106(5):989-997
Doi:10.1542/peds.106.5.989
55. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S and
Evans JK. Rizatriptan 5 mg for the acute treatment of
migraine in adolescents: a randomized, double-blind,
placebo-controlled study.
Headache
2002;42(1):49-
55 Doi:10.1046/j.1526-4610.2002.02013.x
56. 56G R. Netmeta: Network Meta-Analysis using
Frequentist Methods CRAN; 2021.Available from:
https://cran.r-project.org/web/packages/netmeta/
netmeta.pdf.
57. Guido Schwarzer JRC, Gerta Rücker. Meta-Analysis
with R. 3 ed: Springer, Cham; 2015.
58. Bomhof M, Paz J, Legg N, Allen C, Vandormael
K and Patel K. Comparison of rizatriptan 10 mg
vs. naratriptan 2.5 mg in migraine.
Eur Neurol
1999;42(3):173-179 Doi:10.1159/000008094
59. Bousser MG, D'Allens H and Richard A. Efficacy of
subcutaneous sumatriptan in the acute treatment
of early-morning migraine: a placebo-controlled